Hepatocellular carcinoma

Bubu A. Banini, Lewis Rowland Roberts

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related deaths worldwide, with an estimated 782,000 new cases and 746,000 deaths from HCC in 2012 alone. The highest rates of HCC occur in Southeast Asia and sub-Saharan Africa, where the primary etiology is hepatitis B virus infection. Over the past few decades, Europe and the USA have also experienced substantial increases in HCC incidence and mortality mainly as a result of hepatitis C virus-associated cirrhosis. In many patients, the coexistence of HCC and cirrhosis complicates prognostic assessment and treatment. In this chapter, we provide an overview of the pathophysiology of HCC, recommendations for screening and diagnosis, and an up-to-date summary of the current therapies and future directions in management of this complex disease.

Original languageEnglish (US)
Title of host publicationComplications of Cirrhosis: Evaluation and Management
PublisherSpringer International Publishing
Pages207-218
Number of pages12
ISBN (Print)9783319136141, 9783319136134
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hepatocellular Carcinoma
Fibrosis
Southeastern Asia
Africa South of the Sahara
Virus Diseases
Disease Management
Hepatitis B virus
Hepacivirus
Mortality
Incidence
Therapeutics
Neoplasms

Keywords

  • BCLC staging
  • Liver transplantation
  • Radiofrequency ablation
  • Sorafenib
  • Transarterial chemoembolization
  • Transarterial radioembolization

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Banini, B. A., & Roberts, L. R. (2015). Hepatocellular carcinoma. In Complications of Cirrhosis: Evaluation and Management (pp. 207-218). Springer International Publishing. https://doi.org/10.1007/978-3-319-13614-1_22

Hepatocellular carcinoma. / Banini, Bubu A.; Roberts, Lewis Rowland.

Complications of Cirrhosis: Evaluation and Management. Springer International Publishing, 2015. p. 207-218.

Research output: Chapter in Book/Report/Conference proceedingChapter

Banini, BA & Roberts, LR 2015, Hepatocellular carcinoma. in Complications of Cirrhosis: Evaluation and Management. Springer International Publishing, pp. 207-218. https://doi.org/10.1007/978-3-319-13614-1_22
Banini BA, Roberts LR. Hepatocellular carcinoma. In Complications of Cirrhosis: Evaluation and Management. Springer International Publishing. 2015. p. 207-218 https://doi.org/10.1007/978-3-319-13614-1_22
Banini, Bubu A. ; Roberts, Lewis Rowland. / Hepatocellular carcinoma. Complications of Cirrhosis: Evaluation and Management. Springer International Publishing, 2015. pp. 207-218
@inbook{532c1054a5144d4893629c2713a489fb,
title = "Hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related deaths worldwide, with an estimated 782,000 new cases and 746,000 deaths from HCC in 2012 alone. The highest rates of HCC occur in Southeast Asia and sub-Saharan Africa, where the primary etiology is hepatitis B virus infection. Over the past few decades, Europe and the USA have also experienced substantial increases in HCC incidence and mortality mainly as a result of hepatitis C virus-associated cirrhosis. In many patients, the coexistence of HCC and cirrhosis complicates prognostic assessment and treatment. In this chapter, we provide an overview of the pathophysiology of HCC, recommendations for screening and diagnosis, and an up-to-date summary of the current therapies and future directions in management of this complex disease.",
keywords = "BCLC staging, Liver transplantation, Radiofrequency ablation, Sorafenib, Transarterial chemoembolization, Transarterial radioembolization",
author = "Banini, {Bubu A.} and Roberts, {Lewis Rowland}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-13614-1_22",
language = "English (US)",
isbn = "9783319136141",
pages = "207--218",
booktitle = "Complications of Cirrhosis: Evaluation and Management",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Hepatocellular carcinoma

AU - Banini, Bubu A.

AU - Roberts, Lewis Rowland

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related deaths worldwide, with an estimated 782,000 new cases and 746,000 deaths from HCC in 2012 alone. The highest rates of HCC occur in Southeast Asia and sub-Saharan Africa, where the primary etiology is hepatitis B virus infection. Over the past few decades, Europe and the USA have also experienced substantial increases in HCC incidence and mortality mainly as a result of hepatitis C virus-associated cirrhosis. In many patients, the coexistence of HCC and cirrhosis complicates prognostic assessment and treatment. In this chapter, we provide an overview of the pathophysiology of HCC, recommendations for screening and diagnosis, and an up-to-date summary of the current therapies and future directions in management of this complex disease.

AB - Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related deaths worldwide, with an estimated 782,000 new cases and 746,000 deaths from HCC in 2012 alone. The highest rates of HCC occur in Southeast Asia and sub-Saharan Africa, where the primary etiology is hepatitis B virus infection. Over the past few decades, Europe and the USA have also experienced substantial increases in HCC incidence and mortality mainly as a result of hepatitis C virus-associated cirrhosis. In many patients, the coexistence of HCC and cirrhosis complicates prognostic assessment and treatment. In this chapter, we provide an overview of the pathophysiology of HCC, recommendations for screening and diagnosis, and an up-to-date summary of the current therapies and future directions in management of this complex disease.

KW - BCLC staging

KW - Liver transplantation

KW - Radiofrequency ablation

KW - Sorafenib

KW - Transarterial chemoembolization

KW - Transarterial radioembolization

UR - http://www.scopus.com/inward/record.url?scp=84944561250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944561250&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-13614-1_22

DO - 10.1007/978-3-319-13614-1_22

M3 - Chapter

AN - SCOPUS:84944561250

SN - 9783319136141

SN - 9783319136134

SP - 207

EP - 218

BT - Complications of Cirrhosis: Evaluation and Management

PB - Springer International Publishing

ER -